Abstract

Modification of the membrane lipid phosphatidylglycerol (PG) of Staphylococcus aureus by enzymatic transfer of a l-lysine residue leading to lysyl-PG converts the net charge of PG from -1 to +1 and is thought to confer resistance to cationic antimicrobial peptides (AMPs). Lysyl-PG synthesis and translocation to the outer leaflet of the bacterial membrane are achieved by the membrane protein MprF. Consequently, mutants lacking a functional mprF gene are in particular vulnerable to the action of AMPs. Hence, we aim at elucidating whether and to which extent lysyl-PG modulates membrane binding, insertion, and permeabilization by various AMPs. Lysyl-PG was incorporated into artificial lipid bilayers, mimicking the cytoplasmic membrane of S. aureus. Moreover, we determined the activity of the peptides against a clinical isolate of S. aureus strain SA113 and two mutants lacking a functional mprF gene and visualized peptide-induced ultrastructural changes of bacteria by transmission electron microscopy. The studied peptides were: (i) NK-2, an α-helical fragment of mammalian NK-lysin, (ii) arenicin-1, a lugworm β-sheet peptide, and (iii) bee venom melittin. Biophysical data obtained by FRET spectroscopy, Fourier transform infrared spectroscopy, and electrical measurements with planar lipid bilayers were correlated with the biological activities of the peptides. They strongly support the hypothesis that peptide-membrane interactions are a prerequisite for eradication of S. aureus. However, degree and mode of modulation of membrane properties such as fluidity, capacitance, and conductivity were unique for each of the peptides. Altogether, our data support and underline the significance of lysyl-PG for S. aureus resistance to AMPs.

Highlights

  • The opportunistic pathogen Staphylococcus aureus is among the bacteria that are difficult to treat, by cationic antibiotics and antimicrobial peptides (AMPs) [14, 15]

  • The lipid portion of the cytoplasmic membrane of S. aureus is composed of PG and cardiolipin [16, 17], and it has been estimated that one-third of PG in the membrane is modified by lysine

  • Antibacterial Activity—We determined the capability of synthetic cationic peptides (Table 1) to inhibit the growth (MIC) and to kill various strains of S. aureus

Read more

Summary

Introduction

The opportunistic pathogen Staphylococcus aureus is among the bacteria that are difficult to treat, by cationic antibiotics and AMPs [14, 15]. We aim at elucidating the significance and effects of a partial substitution of PG by lysyl-PG in model membranes, to mimic the cytoplasmic membrane of bacterial strains expressing or lacking the functional MprF protein, on the interaction with representative AMPs. The studied peptides were well characterized and exhibit profound activities against a clinical isolate of S. aureus (see Table 1).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call